Human Xtensions Ltd (HUMX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Human Xtensions Ltd (HUMX) has a cash flow conversion efficiency ratio of -0.626x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-2.06 Million ≈ $-5.51K USD) by net assets (ILA3.29 Million ≈ $8.81K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HUMX equity to assets ratio to measure how much of total assets are equity-financed.
Human Xtensions Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Human Xtensions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Human Xtensions Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Human Xtensions Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Human Xtensions Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vision Lithium Inc
V:VLI
|
-0.007x |
|
Fsport AB
ST:FSPORT
|
0.215x |
|
Blackrock Energy and Resources Income Trust PLC
LSE:BERI
|
0.014x |
|
Hadasit Bio
TA:HDST
|
-0.033x |
|
District Copper Corp
V:DCOP
|
-0.071x |
|
Downing Renewables & Infrastructure Trust PLC
LSE:DORE
|
0.022x |
|
Martello Technologies Group Inc
V:MTLO
|
0.035x |
|
NOVRA TECHNOLOGIES INC.
F:7CV
|
-0.231x |
Annual Cash Flow Conversion Efficiency for Human Xtensions Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of Human Xtensions Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Human Xtensions Ltd (HUMX) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA2.91 Million ≈ $7.81K |
ILA-20.84 Million ≈ $-55.88K |
-7.156x | -444.52% |
| 2023-12-31 | ILA26.11 Million ≈ $69.99K |
ILA-34.31 Million ≈ $-91.97K |
-1.314x | -94.54% |
| 2022-12-31 | ILA61.78 Million ≈ $165.63K |
ILA-41.73 Million ≈ $-111.88K |
-0.675x | -67.38% |
| 2021-12-31 | ILA104.53 Million ≈ $280.25K |
ILA-42.19 Million ≈ $-113.10K |
-0.404x | -120.35% |
| 2020-12-31 | ILA148.82 Million ≈ $398.99K |
ILA-27.26 Million ≈ $-73.08K |
-0.183x | +86.26% |
| 2019-12-31 | ILA20.43 Million ≈ $54.77K |
ILA-27.24 Million ≈ $-73.03K |
-1.333x | +19.80% |
| 2018-12-31 | ILA15.51 Million ≈ $41.57K |
ILA-25.78 Million ≈ $-69.12K |
-1.663x | -- |
About Human Xtensions Ltd
Human Xtensions Ltd., a medical robotics company, develops, manufactures, markets, and sells modular medical device for minimally invasive surgical operations in Israel. The company offers HandX, a handheld smart laparoscopy solution for use in laparoscopic surgeries; fenestrated grasper; monopolar hook; monopolar spatula; monopolar scissors; self-righting needle holder; and needle holder. Human … Read more